Clinical Trial Update: Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on suprachoroidal CLS-TA alone or with aflibercept in diabetic macular edema (Phase 1/2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• CLS-TA (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-19